Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related TEVA
8 Stocks Which Plummeted Three Days On Increasing Volume
Will Allergan Buy Gilead? Don't Count On 'The Mother Of All Blockbusters'
Amgen Migraine Drug Likely To Beat Eli Lilly, Alder, Teva To Market (Investor's Business Daily)
Related JASO
Solar Stocks Shine On Heels Of California Utilities Decision
The Market In 5 Minutes: Retailers Keep The Earnings Party Going
Solar Stocks To Own For 2017 (Seeking Alpha)

Analysts at Morgan Stanley upgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “underweight” to “equal-weight.” The price target for Teva Pharmaceutical is set to $52. Teva Pharmaceutical's shares closed at $47.96 yesterday.

Axiom upgraded JA Solar Holdings Co (NASDAQ: JASO) from “undefined” to “buy.” The price target for JA Solar is set to $16. JA Solar's shares closed at $10.55 yesterday.

Analysts at Keefe Bruyette & Woods upgraded Independent Bank (NASDAQ: INDB) from “market perform” to “outperform.” The price target for Independent Bank has been raised from $40 to $44. Independent Bank's shares closed at $38.11 yesterday.

Oppenheimer upgraded Lowe's Companies (NYSE: LOW) from “market perform” to “outperform.” The price target for Lowe's Companies has been raised from $50 to $57. Lowe's shares closed at $48.71 yesterday.

Latest Ratings for TEVA

DateFirmActionFromTo
Sep 2016OTR GlobalInitiates Coverage onPositive
Sep 2016OppenheimerUpgradesPerformOutperform
Aug 2016Leerink SwannMaintainsOutperform

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (INDB + JASO)

View Comments and Join the Discussion!